Transforming growth factor-β1 and fibrosis in congenital muscular dystrophies

Neuromuscular Disorders

Volumn 9, Issue 1, 1999, Pages 28-33

  Bernasconi, Pia ^a   Di Blasi, Claudia ^a   Mora, Marina ^a   Morandi, Lucia ^a   Galbiati, Silvia ^a   Confalonieri, Paolo ^a   Cornelio, Ferdinando ^a   Mantegazza, Renato ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Congenital muscular dystrophy; Muscle fibrotic degeneration; Transforming growth factor 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COLLAGEN SYNTHESIS; CONNECTIVE TISSUE; CONTROLLED STUDY; FEMALE; FIBROGENESIS; FIBROSIS; HISTOPATHOLOGY; HUMAN; INFANT; MALE; MOTOR PERFORMANCE; MUSCLE BIOPSY; MUSCULAR DYSTROPHY; ONSET AGE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TISSUE LEVEL;

ADULT; CHILD; CHILD, PRESCHOOL; CONNECTIVE TISSUE; FEMALE; FIBROSIS; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; LAMININ; MALE; MUSCULAR DYSTROPHIES; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032991133     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(98)00093-5     Document Type: Article

References (21)

1. Sanes JR. The extracellular matrix. In: Engel AG, Franzini-Armstrong C, editors. Myology, Volume 1. New York: McGraw-Hill, 1994:242-260.
2. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. N Engl J Med 1994;331:1286-1292.
3. Confalonieri P, Bernasconi P, Cornelio F, Mantegazza R. Transforming growth factor-β1 in polymyositis and dermatomyositis correlates with fibrosis but not with mononuclear cell infiltrate. J Neuropathol Exp Neurol 1997;56:479-484.
4. Yamazaki MS, Minota H, Sakurai K, et al. Expression of transforming growth factor-β1 and its relation to endomysial fibrosis in progressive muscular dystrophy. Am J Pathol 1994;144:221-226.
5. Bernasconi P, Torchiana E, Confalonieri P, et al. Expression of transforming growth factor-β1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine. J Clin Invest 1995;96:1137-1144.
6. Banker BQ. The congenital muscular dystrophies. In: Engel AG, Franzini-Armstrong C, editors. Myology, Volume 1. New York: McGraw-Hill, 1994:1275-1289.
7. Tomé FMS, Evangelista T, Leclerc A, et al. Congenital muscular dystrophy with merosin deficiency. C R Acad Sci Paris 1994;317: 351-357.
8. Kobayashi O, Hayashi Y, Arahata K, Ozawa E, Nonaka I. Congenital muscular dystrophy: clinical and pathological study of 50 patients with the classical (occidental) merosin-positive form. Neurology 1996;46:815-818.
9. Prelle A, Comi GP, Rigoletto C, et al. An atypical case of partial merosin deficiency congenital muscular dystrophy. J Neurol 1997; 244:391-395.
10. Mora M, Moroni I, Uziel G, et al. Mild clinical phenotype in a 12-year-old boy with partial merosin deficiency and central and peripheral nervous system abnormalities. Neuromusc Disord 1996;6:377-381.
11. Stephens HR, Duance VC, Dunn MJ, Bailey AJ, Dubowitz V. Collagen types in neuromuscular diseases. J Neurol Sci 1982;53:45-62.
12. Schuler F, Sorokin LM. Expression of laminin isoforms in mouse myogenic cells in vitro and in vivo. J Cell Sci 1995;108:3795-3805.
13. Sewry CA, Naom I, D'Alessandro M, et al. Variable clinical phenotype in merosin-deficient congenital muscular dystrophy associated with differential immunolabelling of two fragments of the laminin α2 chain. Neuromusc Disord 1997;7:169-175.
14. Cannella B, Raine CS. The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann Neurol 1995;37:424-435.
15. Jullien P, Berg TM, Laurence DA. Acidic cellular environments: activation of latent TGF-β and sensitization of cellular responses to TGF-β and EGF. Int J Cancer 1989;43:886-891.
16. Arahata K, Engel AG. Monoclonal antibody analysis of mononuclear cells in myopathies: I. Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibres invaded by T cells. Ann Neurol 1984;16:193-208.
17. Cornelio F, Dones I. Muscle fibre degeneration and necrosis in muscular dystrophy and other muscle diseases: cytochemical and immunocytochemical data. Ann Neurol 1984;16:694-701.
18. Ehrig K, Leivo I, Argraves WS, Ruoslahti E, Engvall E. Merosin, a tissue-specific basement membrane protein, is a laminin-like protein. Proc Natl Acad Sci USA 1990;87:3264-3268.
19. Ruoslahti E, Reed JC. Anchorage dependence, integrins, and apoptosis. Cell 1994;77:477-478.
20. Clark EA, Brugge JS. Integrins and signal transduction pathways: the road taken. Science 1995;268:233-239.
21. Vachon PH, Loechel F, Xu H, Wewer UM, Engvall E. Merosin and laminin in myogenesis; specific requirement for merosin in myotube stability and survival. J Cell Biol 1996;134:1483-1497.